Recommended Topic Related To:

Neuraceq

"The US Food and Drug Administration (FDA) has approved a fixed-dose combination of memantine hydrochloride extended-release (XR) and donepezil hydrochloride (Namzaric, Actavis plc/Adamas Pharm) for moderate to severe Alzheimer's-related de"...

Neuraceq

PATIENT INFORMATION

  • Instruct patients to inform their physician or healthcare provider if they are pregnant or breastfeeding.
  • Inform patients who are breastfeeding to use alternate infant nutrition sources (e.g. stored breast milk or infant formula) for 24 hours ( > 10 half-lives of radioactive decay for the F 18 isotope) after administration of the drug or to avoid use of the drug.

Last reviewed on RxList: 3/31/2014
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.